Retatrutide in North Carolina (2026)
retatrutide · GLP-1 weight management · North Carolina
About Retatrutide
Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.
See the full Retatrutide review for dosing, efficacy data, side effects, and the full pharmacy + telehealth program comparison.
Insurance coverage for Retatrutide in North Carolina
NC Medicaid covers GLP-1s for weight management with prior authorization (criteria effective August 1, 2024). Coverage was paused on October 1, 2025 and reinstated on December 12, 2025. Wegovy is the preferred drug; Zepbound and Saxenda require a trial of Wegovy first.
We do not track carrier-level coverage for Retatrutide. Check your plan's formulary or our insurance hub.
Telehealth and prescribing in North Carolina
A telehealth clinician must be licensed in North Carolina to prescribe Retatrutide to you while you are in North Carolina.
North Carolina joined the Interstate Medical Licensure Compact effective January 1, 2026 (Session Law 2025-37).
- Source: NC Medical Board: IMLC
Platforms differ in which drugs they prescribe, insurance handling, and clinical model. See our platform comparisons.
Compounded retatrutide
On April 30, 2026, FDA proposed not to include semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which would stop outsourcing facilities from compounding them from bulk ingredients. The comment period was extended to July 30, 2026. As of September 15, 2026, no final decision has been published. The proposal does not address 503A compounding for an individual patient's documented clinical need.
Retatrutide in North Carolina: common questions
Is Retatrutide legal in North Carolina?+
Yes. Retatrutide (retatrutide) is FDA-approved and legal in all 50 US states including North Carolina. State-level differences appear in Medicaid coverage and clinician licensing, not in the legality of the medication itself.
Can I get Retatrutide via telehealth in North Carolina?+
Yes, from a clinician licensed in North Carolina. A telehealth clinician must be licensed in North Carolina to prescribe Retatrutide to you while you are in North Carolina. North Carolina joined the Interstate Medical Licensure Compact effective January 1, 2026 (Session Law 2025-37).
Does North Carolina Medicaid cover Retatrutide?+
Covered with prior authorization for weight loss. NC Medicaid covers GLP-1s for weight management with prior authorization (criteria effective August 1, 2024). Coverage was paused on October 1, 2025 and reinstated on December 12, 2025. Wegovy is the preferred drug; Zepbound and Saxenda require a trial of Wegovy first.
What's the cheapest way to get Retatrutide in North Carolina?+
The main paths are insurance with prior authorization if your plan covers it, manufacturer cash-pay programs, or telehealth programs that include the medication. NovoCare Pharmacy sells Wegovy pens to cash-pay patients for $349 a month ($199 a month for the first two months for new patients through December 31, 2026). LillyDirect sells Zepbound vials for $299 (2.5 mg), $399 (5 mg), and $449 (7.5 to 15 mg) a month when refilled on time.
Is compounded Retatrutide still available in North Carolina?+
Compounding rules are federal, not set by North Carolina. On April 30, 2026, FDA proposed not to include semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which would stop outsourcing facilities from compounding them from bulk ingredients. The comment period was extended to July 30, 2026. As of September 15, 2026, no final decision has been published. The proposal does not address 503A compounding for an individual patient's documented clinical need.